Diabetes, Vol 46, Issue 4 653-658, Copyright © 1997 by American Diabetes Association

ARTICLES

Nitric oxide and ocular blood flow in patients with IDDM

L Schmetterer, O Findl, P Fasching, W Ferber, K Strenn, H Breiteneder, H Adam, HG Eichler and M Wolzt
Department of Clinical Pharmacology, Vienna University School of Medicine, Austria.

Endothelial dysfunction has been implicated in the pathogenesis of diabetic vascular disorders such as diabetic retinopathy. We hypothesized that either local endogenous nitric oxide (NO) synthesis or local reactivity to endogenous NO might be impaired in patients with IDDM and that this may contribute to the development of diabetic retinopathy. Ten otherwise healthy patients with long-standing IDDM and ten healthy control subjects were studied according to an open randomized two-way cross-over design. Subjects received intravenous infusions of either N(G)-monomethyl-L-arginine, an inhibitor of NO-synthase, or L-arginine, the precursor of NO synthesis, on two separate study days. Ocular hemodynamics were assessed by laser interferometric measurement of fundus pulsations and Doppler sonographic measurement of blood flow velocity in the ophthalmic artery. N(G)-monomethyl-L-arginine decreased fundus pulsations and blood flow velocity in the ophthalmic artery and increased blood pressure in healthy subjects. The responses to NO-synthase inhibition were significantly less in diabetic subjects. In contrast, L-arginine caused a comparable increase in fundus pulsations and decrease in blood pressure in both cohorts. These results indicate that systemic and ocular hemodynamic reactivity to NO-synthase inhibition is reduced in patients with long-standing IDDM, compared with healthy control subjects. Thus, this study indicates that either NO-synthase activity is increased or NO sensitivity is decreased in patients with IDDM and supports the concept of an involvement of the L-arginine-NO system in the pathophysiology of diabetic retinopathy.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. Jiang, B. Mysona, Y. Dun, J. P. Gnana-Prakasam, N. Pabla, W. Li, Z. Dong, V. Ganapathy, and S. B. Smith Expression, Subcellular Localization, and Regulation of Sigma Receptor in Retinal Muller Cells Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5576 - 5582. [Abstract] [Full Text] [PDF]

				E. Polska, J. Kolodjaschna, F. Berisha, M. M. Malec, C. Simader, M. Bayerle-Eder, M. Roden, and L. Schmetterer C-Peptide does not affect ocular blood flow in patients with type 1 diabetes. Diabetes Care, September 1, 2006; 29(9): 2034 - 2038. [Abstract] [Full Text] [PDF]

				A Grosso, F Veglio, M Porta, F M Grignolo, and T Y Wong Hypertensive retinopathy revisited: some answers, more questions Br. J. Ophthalmol., December 1, 2005; 89(12): 1646 - 1654. [Abstract] [Full Text] [PDF]

				C. Delles, G. Michelson, J. Harazny, S. Oehmer, K. F. Hilgers, and R. E. Schmieder Impaired Endothelial Function of the Retinal Vasculature in Hypertensive Patients Stroke, June 1, 2004; 35(6): 1289 - 1293. [Abstract] [Full Text] [PDF]

				Y. P. R. Jarajapu, M. B. Grant, and H. J. Knot Myogenic Tone and Reactivity of the Rat Ophthalmic Artery Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 253 - 259. [Abstract] [Full Text] [PDF]

				G. T. Dorner, G. Garhofer, B. Kiss, E. Polska, K. Polak, C. E. Riva, and L. Schmetterer Nitric oxide regulates retinal vascular tone in humans Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H631 - H636. [Abstract] [Full Text] [PDF]

				S. Dallinger, A. Sieder, J. Strametz, M. Bayerle-Eder, M. Wolzt, and L. Schmetterer Vasodilator effects of L-arginine are stereospecific and augmented by insulin in humans Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1106 - E1111. [Abstract] [Full Text] [PDF]

				G. Fuchsjager-Mayrl, J. Pleiner, G. F. Wiesinger, A. E. Sieder, M. Quittan, M. J. Nuhr, C. Francesconi, H.-P. Seit, M. Francesconi, L. Schmetterer, et al. Exercise Training Improves Vascular Endothelial Function in Patients with Type 1 Diabetes Diabetes Care, October 1, 2002; 25(10): 1795 - 1801. [Abstract] [Full Text] [PDF]

				H. Naggar, M. S. Ola, P. Moore, W. Huang, C. C. Bridges, V. Ganapathy, and S. B. Smith Downregulation of Reduced-Folate Transporter by Glucose in Cultured RPE Cells and in RPE of Diabetic Mice Invest. Ophthalmol. Vis. Sci., February 1, 2002; 43(2): 556 - 563. [Abstract] [Full Text] [PDF]

				C. C. Bridges, M. S. Ola, P. D. Prasad, A. El-Sherbeny, V. Ganapathy, and S. B. Smith Regulation of taurine transporter expression by NO in cultured human retinal pigment epithelial cells Am J Physiol Cell Physiol, December 1, 2001; 281(6): C1825 - C1836. [Abstract] [Full Text] [PDF]

				K. Polak, L. Schmetterer, A. Luksch, S. Gruber, E. Polska, V. Peternell, M. Bayerle-Eder, M. Wolzt, M. Krebs, and M. Roden Free fatty acids/triglycerides increase ocular and subcutaneous blood flow Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R56 - R61. [Abstract] [Full Text] [PDF]

				K. Polak, G. Dorner, B. Kiss, E. Polska, O. Findl, G. Rainer, H.-G. Eichler, and L. Schmetterer Evaluation of the Zeiss retinal vessel analyser Br. J. Ophthalmol., November 1, 2000; 84(11): 1285 - 1290. [Abstract] [Full Text] [PDF]

				A. Luksch, K. Polak, C. Beier, E. Polska, M. Wolzt, G. T. Dorner, H.-G. Eichler, and L. Schmetterer Effects of Systemic NO Synthase Inhibition on Choroidal and Optic Nerve Head Blood Flow in Healthy Subjects Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 3080 - 3084. [Abstract] [Full Text]

				D. M. Gamm, L. K. Barthel, P. A. Raymond, and M. D. Uhler Localization of cGMP-Dependent Protein Kinase Isoforms in Mouse Eye Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2766 - 2773. [Abstract] [Full Text]

				O. Findl, S. Dallinger, B. Rami, K. Polak, E. Schober, A. Wedrich, E. Ries, H.-G. Eichler, M. Wolzt, and L. Schmetterer Ocular haemodynamics and colour contrast sensitivity in patients with type 1 diabetes Br. J. Ophthalmol., May 1, 2000; 84(5): 493 - 498. [Abstract] [Full Text]

				L.-O. Hattenbach, A. Allers, C. Klais, F. Koch, and M. Hecker L-Arginine-Nitric Oxide Pathway-Related Metabolites in the Aqueous Humor of Diabetic Patients Invest. Ophthalmol. Vis. Sci., January 1, 2000; 41(1): 213 - 217. [Abstract] [Full Text]

				T. Kawagishi, M. Matsuyoshi, M. Emoto, H. Taniwaki, H. Kanda, Y. Okuno, M. Inaba, E. Ishimura, Y. Nishizawa, and H. Morii Impaired Endothelium-Dependent Vascular Responses of Retinal and Intrarenal Arteries in Patients With Type 2 Diabetes Arterioscler. Thromb. Vasc. Biol., October 1, 1999; 19(10): 2509 - 2516. [Abstract] [Full Text] [PDF]

				B. Kiss, S. Dallinger, O. Findl, G. Rainer, H.-G. Eichler, and L. Schmetterer Acetazolamide-induced cerebral and ocular vasodilation in humans is independent of nitric oxide Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1661 - R1667. [Abstract] [Full Text] [PDF]

				G. M. Pieper Review of Alterations in Endothelial Nitric Oxide Production in Diabetes : Protective Role of Arginine on Endothelial Dysfunction Hypertension, May 1, 1998; 31(5): 1047 - 1060. [Full Text] [PDF]

				L. Schmetterer, O. Findl, K. Strenn, U. Graselli, J. Kastner, H.-G. Eichler, and M. Wolzt Role of NO in the O2 and CO2 responsiveness of cerebral and ocular circulation in humans Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1997; 273(6): R2005 - R2012. [Abstract] [Full Text] [PDF]

				S. M. Fitzgerald and M. W. Brands Hypertension in L-NAME-treated diabetic rats depends on an intact sympathetic nervous system Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2002; 282(4): R1070 - R1076. [Abstract] [Full Text] [PDF]